E Trav Tech Limited
₹ 0▲0.00%(0.00)
About the company
Etrav Tech Limited is a technology-driven B2B travel platform that enables travel agents across India to efficiently manage and grow their businesses through a comprehensive suite of travel booking solutions. By combining advanced technology with a wide network of travel suppliers, the company provides seamless access to flights, hotels, holiday packages, and destination services, helping travel partners deliver a better booking experience to their customers.
At the core of Etrav's operations is its proprietary travel technology platform, Codemagen, which functions as a powerful travel aggregation engine. The platform consolidates travel inventory from multiple sources and redistributes it through robust API integrations and white-label solutions, allowing travel agencies to offer real-time availability, competitive pricing, customized travel packages, and a smooth digital booking experience. This technology-driven approach enables travel businesses to streamline operations, improve efficiency, and expand their service offerings.
Fundamentals
Valuation
- 52 week high
- —
- 52 week low
- —
- P/B ratio
- 0
- Debt to equity
- 0.09
- ROE (%)
- 14.51%
- Book value
- ₹16.78
- Face value
- ₹2
- Valuation
- —
Registry
- ISIN number
- INE0NQH01022
Figures in cr ·
Financials
| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 7.45 | 19 | 56 | 50 |
| EBITDA | -1.75 | 5 | 20 | 16 |
| OPM | -23.49 | 26.32 | 35.71 | 32 |
| PBT | 4.3 | 20.6 | 25 | 35 |
| PAT | 3.43 | 16.6 | 20 | 28 |
| EPS | 5.58 | 2.57 | 1.8 | 2.44 |
Shareholding Pattern
Leadership
Frequently asked questions
Common questions on E Trav Tech Limited—tap a row to read the answer.
Q.1What are Etrav Tech Limited unlisted shares?
Etrav Tech Limited unlisted shares are equity shares of the company that are not listed on recognized stock exchanges such as the NSE or BSE. These shares are traded through private, off-market transactions and are generally considered by investors looking to participate in the growth of promising private companies before a potential public listing.
Q.2How can I buy Etrav Tech Limited unlisted shares?
To buy Etrav Tech Limited unlisted shares, you need a valid PAN card, completed KYC formalities, and an active demat account. Once a seller is identified and both parties agree on the transaction terms, the shares are transferred through an off-market process and credited to your demat account after payment and documentation are completed.
Q.3Can I sell Etrav Tech Limited unlisted shares before an IPO?
Yes. Etrav Tech Limited unlisted shares can be sold through an off-market transaction even before the company is listed on a stock exchange. The sale depends on the availability of interested buyers, prevailing market demand, and the agreed transaction price between the buyer and seller.
Q.4How is the price of Etrav Tech Limited unlisted shares determined?
The price of Etrav Tech Limited unlisted shares is influenced by several factors, including the company's financial performance, Gross Transaction Value (GTV) growth, business expansion, technology platform, future fundraising plans, market demand, and recent private market transactions. Since the shares are not
Q.5What should I evaluate before investing in Etrav Tech Limited unlisted shares?
Before investing, it is important to assess the company's business model, revenue growth, financial performance, technology capabilities, customer network, management team, scalability, and long-term growth strategy. Investors should also evaluate the outlook for India's digital travel industry and understand the risks associated with investing in unlisted companies.
Q.6Is investing in Etrav Tech Limited unlisted shares legal in India?
Yes. Buying and selling Etrav Tech Limited unlisted shares is legal in India when the transaction is conducted in compliance with applicable regulations. Investors should ensure that the shares are transferred through a valid off-market process and credited to their demat account after completing all required documentation.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
